By Cara Murez
THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have another choice if they want a COVID booster shot.
On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, it had only been approved as a two-dose primary series.
“The U.S. now has access to the Novavax COVID-19 Vaccine, adjuvanted, the first protein-based option, as a booster,” Novavax President and CEO Stanley Erck said in a news release. “According to CDC data, almost 50 percent of adults who received their primary series have yet to receive their first…